BR112021024375A2 - Cápsulas de softgel de liberação retardada - Google Patents

Cápsulas de softgel de liberação retardada

Info

Publication number
BR112021024375A2
BR112021024375A2 BR112021024375A BR112021024375A BR112021024375A2 BR 112021024375 A2 BR112021024375 A2 BR 112021024375A2 BR 112021024375 A BR112021024375 A BR 112021024375A BR 112021024375 A BR112021024375 A BR 112021024375A BR 112021024375 A2 BR112021024375 A2 BR 112021024375A2
Authority
BR
Brazil
Prior art keywords
softgel capsules
delayed release
delayed
capsules
release softgel
Prior art date
Application number
BR112021024375A
Other languages
English (en)
Portuguese (pt)
Inventor
Karunakar Sukuru
Qi Fang
Original Assignee
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=73652472&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112021024375(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scherer Technologies Llc R P filed Critical Scherer Technologies Llc R P
Publication of BR112021024375A2 publication Critical patent/BR112021024375A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
BR112021024375A 2019-06-03 2020-06-02 Cápsulas de softgel de liberação retardada BR112021024375A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962856601P 2019-06-03 2019-06-03
PCT/US2020/035666 WO2020247352A1 (en) 2019-06-03 2020-06-02 Delayed release softgel capsules

Publications (1)

Publication Number Publication Date
BR112021024375A2 true BR112021024375A2 (pt) 2022-04-19

Family

ID=73652472

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021024375A BR112021024375A2 (pt) 2019-06-03 2020-06-02 Cápsulas de softgel de liberação retardada

Country Status (13)

Country Link
US (1) US20220354800A1 (https=)
EP (1) EP3976022A4 (https=)
JP (1) JP7558204B2 (https=)
KR (1) KR20220024189A (https=)
CN (1) CN114072138A (https=)
AR (1) AR119075A1 (https=)
AU (2) AU2020288165B2 (https=)
BR (1) BR112021024375A2 (https=)
CA (1) CA3142702A1 (https=)
CO (1) CO2021018071A2 (https=)
IL (1) IL288653A (https=)
MX (1) MX2021014922A (https=)
WO (1) WO2020247352A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3976022A4 (en) * 2019-06-03 2023-06-14 R.P. Scherer Technologies, LLC DELAYED RELEASE SOFTGEL CAPSULES
KR20230018445A (ko) * 2020-06-02 2023-02-07 알.피.쉐러 테크놀러지즈 엘엘씨 지연 방출 소프트겔 캡슐
JP7830457B2 (ja) * 2020-11-11 2026-03-16 アール．ピー．シェーラー テクノロジーズ，エルエルシー 遅延放出ソフトゲルカプセル
MX2023011596A (es) * 2021-04-01 2023-10-10 Scherer Technologies Llc R P Fosfolipidos como agentes quelantes de aniones en formulaciones farmaceuticas.
WO2023283226A1 (en) * 2021-07-06 2023-01-12 R.P. Scherer Technologies, Llc Softgel capsule
US20250177312A1 (en) * 2022-02-18 2025-06-05 R.P. Scherer Technologies, Llc Modified release valproic acid softgel capsule
DE102022104553A1 (de) * 2022-02-25 2023-08-31 Gelita Ag Magensaftresistente Kapsel und deren Verwendung
AU2023292098A1 (en) * 2022-06-13 2025-01-16 R.P. Scherer Technologies, Llc Enteric bisacodyl softgel capsule
KR20250138712A (ko) * 2022-11-23 2025-09-22 알.피.쉐러 테크놀러지즈 엘엘씨 소프트젤 캡슐 및 소프트젤 캡슐 표시 방법

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778676A (en) * 1985-12-20 1988-10-18 Warner-Lambert Company Confectionery delivery system for actives
EP1184033A1 (en) * 2000-09-01 2002-03-06 Warner-Lambert Company Pectin film compositions
KR20100047349A (ko) * 2001-11-22 2010-05-07 모리시타 진탄 가부시키가이샤 비젤라틴계 캡슐 피막 조성물 및 이를 이용한 캡슐
EP1572164A2 (en) * 2002-12-18 2005-09-14 Pain Therapeutics, Inc. Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats
CN101292965B (zh) * 2007-04-24 2011-12-07 沈阳皓天万嘉医药科技有限公司 一种类β-胡萝卜素微囊及其制备方法
US20100159001A1 (en) * 2008-12-19 2010-06-24 Cardinal John R Extended-Release Pharmaceutical Formulations
CN101461792A (zh) * 2008-12-30 2009-06-24 吴国庆 明胶肠溶胶囊壳材料
CA2805127A1 (en) * 2009-08-05 2011-02-10 7267207 Canada Limited Corporation Process for preparation of over-the-counter gelatin or pectin-based drug delivery
IT1401313B1 (it) * 2010-08-05 2013-07-18 Perfetti Van Melle Spa Caramelle gelatinose con ripieno fluido e metodo di ottenimento
US20120301546A1 (en) 2011-05-26 2012-11-29 Hassan Emadeldin M Acid-resistant soft gel compositions
CN102813275B (zh) * 2011-06-10 2015-09-30 杭州养生堂保健品有限公司 一种咀嚼型软胶囊皮和咀嚼型软胶囊
JP5876695B2 (ja) * 2011-09-29 2016-03-02 森下仁丹株式会社 シームレスカプセルおよびその製造方法
EP2793867B1 (en) * 2011-12-22 2021-01-20 Baes, Erik Gelatin/alginate delayed release capsules comprising omega-3 fatty acids, and methods and uses thereof
CN105101956B (zh) * 2013-01-05 2018-12-07 埃尔舍利克斯治疗公司 包含双胍的延迟释放组合物
US20150366814A1 (en) * 2014-06-23 2015-12-24 Banner Life Sciences Llc All-natural enteric soft capsules comprising active ingredients
PL3191083T3 (pl) * 2014-09-11 2021-07-12 Gelita Ag Cząstki żelatyny/pektyny
AU2015329445B2 (en) * 2014-10-06 2017-11-30 Fuji Capsule Co., Ltd. Method of manufacturing enteric seamless soft capsule
CN104644609B (zh) 2015-01-28 2017-06-16 龙标兵 一种功能性咀嚼型软胶囊皮
US20170119680A1 (en) * 2015-10-30 2017-05-04 R.P. Scherer Technologies, Llc Extended release film-coated capsules
CN108578381A (zh) * 2018-02-27 2018-09-28 广州彤博士健康科技有限公司 可咀嚼性软胶囊外皮的配方及制备方法
EP3976022A4 (en) * 2019-06-03 2023-06-14 R.P. Scherer Technologies, LLC DELAYED RELEASE SOFTGEL CAPSULES

Also Published As

Publication number Publication date
US20220354800A1 (en) 2022-11-10
JP2022535539A (ja) 2022-08-09
MX2021014922A (es) 2022-03-11
AR119075A1 (es) 2021-11-24
TW202110426A (zh) 2021-03-16
AU2025279760A1 (en) 2026-01-15
EP3976022A4 (en) 2023-06-14
CO2021018071A2 (es) 2022-04-19
JP7558204B2 (ja) 2024-09-30
KR20220024189A (ko) 2022-03-03
AU2020288165A1 (en) 2022-01-06
EP3976022A1 (en) 2022-04-06
CN114072138A (zh) 2022-02-18
WO2020247352A1 (en) 2020-12-10
AU2020288165B2 (en) 2026-01-15
IL288653A (en) 2022-02-01
CA3142702A1 (en) 2020-12-10

Similar Documents

Publication Publication Date Title
BR112021024375A2 (pt) Cápsulas de softgel de liberação retardada
MA43518B1 (fr) 3-azabicyclo[3.1.0]hexanes substitués servant d'inhibiteurs de cétohexokinase
HK1251624A1 (zh) Kras表达的调节剂
PH12020500621A1 (en) Enteric softgel capsules
WO2015168635A3 (en) Compositions and methods for modulating complement factor b expression
ZA202005294B (en) Enteric softgel capsules
BR112016028697A2 (pt) artigos que fornecem fragrâncias de longa duração
BR112018001859A2 (pt) comprimido, e, método para produzir um comprimido.
PH12019501293A1 (en) Nutritional compositions containing butyrate and uses thereof
BR112017019400A2 (pt) fertilizante iniciador à base de potássio
BR112014032764A2 (pt) composição farmacêutica contendo fimasartana e hidroclorotiazida
WO2018127612A3 (en) Compositions comprising lespedeza plant extract
BR112018014247A2 (pt) inibição de reação alérgica usando um inibidor il-33
MX2018005456A (es) Capsulas de liberación prolongada recubiertas con película.
BR112012020959A2 (pt) composicao de encapsulamento de liberacao rapida
BR112022024391A2 (pt) Cápsulas de gelatina mole para liberação retardada
MX2020006810A (es) Aleacion que contiene aluminio.
EP4385503A3 (en) Enteric coating for soft capsule
WO2016113754A3 (en) Novel oral dosage forms of dimethyl fumarate
EP4424308A3 (en) Gastro-resistant formulation containing posaconazole and a polymeric precipitation inhibitor
MX379371B (es) Composiciones.
BR112015007566A2 (pt) composição de sabor de camarão e realçador de sabor de camarão
BR112023006154A2 (pt) Cápsulas softgel de liberação modificada
BR112017021120A2 (pt) forma de dosagem de combinação de um antagonista de receptor mu opioide e um agente opioide
MX2020001445A (es) Composiciones de goma de mascar y metodos para su preparacion.

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]